Company Overview of GlaxoSmithKline Pakistan Ltd.
GlaxoSmithKline Pakistan Limited manufactures and markets research based ethical specialties, other pharmaceutical, and consumer products. Its product portfolio includes pharmaceutical medicines, such as anti-infective, analgesic, anti-viral, central nervous system, respiratory, oncology, cardiovascular, gastrointestinal, urology, and anti-allergy drugs, as well as iron preparation and vitamins, and post operation nausea and vomiting drugs. The company also offers vaccines and consumer healthcare products. The company offers its pharmaceutical products under the Augmentin, Seretide, Amoxil, Velosef, Zantac, and Calpol brands; and consumer healthcare products under the Panadol, Horlicks, Aqua...
35, Dockyard Road
Key Executives for GlaxoSmithKline Pakistan Ltd.
GlaxoSmithKline Pakistan Ltd. does not have any Key Executives recorded.
GlaxoSmithKline Pakistan Ltd. Key Developments
GlaxoSmithKline Pakistan Ltd. Reports Earnings Results for the Half Year Ended December 31, 2014
Feb 25 15
GlaxoSmithKline Pakistan Ltd. reported earnings results for the half year ended December 31, 2014. For the period, the company reported profit after tax of PKR 1,687,071,000 or PKR 5.30 per share.
GlaxoSmithKline Pakistan Ltd., Board Meeting, Feb 25, 2015
Feb 18 15
GlaxoSmithKline Pakistan Ltd., Board Meeting, Feb 25, 2015., at 13:00 Pakistan Standard Time. Agenda: To consider financial results for the year ended December 31, 2014.
GlaxoSmithKline Pakistan Ltd. to Report Fiscal Year 2014 Results on Feb 25, 2015
Feb 18 15
GlaxoSmithKline Pakistan Ltd. announced that they will report fiscal year 2014 results on Feb 25, 2015
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|